Aprogen Acquires Additional 100 Million Shares of Subsidiary Aprogen Pharmaceuticals
[Asia Economy Reporter Gong Byung-sun] Aprogen announced on the 4th that it will additionally acquire 100 million shares of its pharmaceutical manufacturing and sales affiliate, Aprogen Pharm, for 50 billion KRW.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Trump’s Approval Rating Drops to 37%, Lowest Since Return to Office
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
After the stock acquisition, Aprogen's stake in Aprogen Pharm will be 56%. The scheduled date for the stock acquisition is December 10. Aprogen stated, "The shares were acquired for the purpose of investing in new business."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
